NP90323(b) Botulinum Toxin Type A Medicines (Dysport®)
Supply of Botulinum Toxin Type A Medicines(Dysport®) to NHS Scotland: NP90323(b): Botulinum Toxin Type A Injection 300-unit vial/ Botulinum Toxin Type A Injection 500-unit vial (Dysport®)
Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Value
£1,033,932
Published
17 Nov 2023
Closes
17 Nov 2023
Procurement details
Source
Pcs
Region
Scotland
Procurement method
Limited
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot 1 NP90323(b) Botulinum Toxin Type A Medicines (Dysport®)
£1,033,932
The Framework Agreement is for the supply of Botulinum Toxin Type A (Dysport®) to NHS Scotland. The Framework Agreement has been awarded as a Single supplier framework agreement to one (1) Framework Participant.
Delivery: Scotland
Documents
Unlock document linkNP90323(b) Botulinum Toxin Type A Medicines (Dysport®)
Not provided
Supply of Botulinum Toxin Type A Medicines(Dysport®) to NHS Scotland: NP90323(b): Botulinum Toxin Type A Injection 300-unit vial/ Botulinum Toxin Type A Injection 500-unit vial (Dysport®)
Award notice · Web page
NP90323(b) Botulinum Toxin Type A Medicines (Dysport®)
Not provided
Supply of Botulinum Toxin Type A Medicines(Dysport®) to NHS Scotland: NP90323(b): Botulinum Toxin Type A Injection 300-unit vial/ Botulinum Toxin Type A Injection 500-unit vial (Dysport®)
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.